Marc Vekemans

583 total citations
20 papers, 335 citations indexed

About

Marc Vekemans is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marc Vekemans has authored 20 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Marc Vekemans's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (3 papers) and HIV-related health complications and treatments (3 papers). Marc Vekemans is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (3 papers) and HIV-related health complications and treatments (3 papers). Marc Vekemans collaborates with scholars based in Belgium, United States and Switzerland. Marc Vekemans's co-authors include Éric Florence, Erika Vlieghe, Ellen Van Gulck, Guido Vanham, Nathalie Cools, Winni De Haes, Zwi Berneman, Aspasia Georgala, Viggo Van Tendeloo and Panagiotis Fanourgiakis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and AIDS.

In The Last Decade

Marc Vekemans

20 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Vekemans Belgium 10 142 98 77 77 67 20 335
David Shasha Israel 13 213 1.5× 64 0.7× 157 2.0× 85 1.1× 71 1.1× 27 481
Barbara Falkensammer Austria 13 203 1.4× 48 0.5× 69 0.9× 166 2.2× 112 1.7× 31 431
Anokhi J. Kapasi United States 7 106 0.7× 68 0.7× 217 2.8× 38 0.5× 49 0.7× 8 322
Elizabeth Freda O. Telan Japan 13 180 1.3× 49 0.5× 90 1.2× 107 1.4× 32 0.5× 26 395
Hannah L. Itell United States 14 165 1.2× 71 0.7× 166 2.2× 140 1.8× 59 0.9× 23 432
Ming Chang United States 12 191 1.3× 83 0.8× 214 2.8× 66 0.9× 175 2.6× 30 585
Marissa B. Wilck United States 11 141 1.0× 91 0.9× 390 5.1× 123 1.6× 110 1.6× 24 560
Mark K. Sachs United States 9 225 1.6× 67 0.7× 150 1.9× 41 0.5× 135 2.0× 18 469
Margaret Duffy Ireland 9 87 0.6× 52 0.5× 197 2.6× 185 2.4× 107 1.6× 16 515
Matthew M. Hernandez United States 9 207 1.5× 57 0.6× 83 1.1× 55 0.7× 44 0.7× 18 368

Countries citing papers authored by Marc Vekemans

Since Specialization
Citations

This map shows the geographic impact of Marc Vekemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Vekemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Vekemans more than expected).

Fields of papers citing papers by Marc Vekemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Vekemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Vekemans. The network helps show where Marc Vekemans may publish in the future.

Co-authorship network of co-authors of Marc Vekemans

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Vekemans. A scholar is included among the top collaborators of Marc Vekemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Vekemans. Marc Vekemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tré‐Hardy, Marie, et al.. (2021). Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. Journal of Infection. 83(5). 559–564. 48 indexed citations
2.
Vekemans, Marc, et al.. (2021). Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis. BMJ Case Reports. 14(6). e241067–e241067. 4 indexed citations
3.
Kanobana, Kirezi, Katja Polman, Patrick Soentjens, et al.. (2015). Toxocariasis Diagnosed in International Travelers at the Institute of Tropical Medicine, Antwerp, Belgium, from 2000 to 2013. PLoS neglected tropical diseases. 9(3). e0003559–e0003559. 24 indexed citations
4.
5.
Bergh, Rafaël Van den, Sébastien Morin, Hans Jürgen Sass, et al.. (2012). Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT. PLoS ONE. 7(4). e35074–e35074. 34 indexed citations
6.
Gulck, Ellen Van, Nathalie Cools, Derek Atkinson, et al.. (2012). Interleukin-12p70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulategag-Specific Immune Responses. SHILAP Revista de lepidopterología. 2012. 1–11. 6 indexed citations
7.
Haes, Winni De, Joanna Rejman, Charlotte Pollard, et al.. (2012). Lipoplexes Carrying mRNA Encoding Gag Protein Modulate Dendritic Cells to Stimulate HIV-Specific Immune Responses. Nanomedicine. 8(1). 77–87. 15 indexed citations
8.
Peterson, Kevin, Jean Ruelle, Marc Vekemans, et al.. (2012). The Role of Raltegravir in the Treatment of HIV-2 Infections: Evidence from a Case Series. Antiviral Therapy. 17(6). 1097–1100. 11 indexed citations
9.
Bottieau, Emmanuel, Marc Vekemans, & Alfons Van Gompel. (2011). Therapy of vector-borne protozoan infections in nonendemic settings. Expert Review of Anti-infective Therapy. 9(5). 583–608. 3 indexed citations
10.
Gulck, Ellen Van, Erika Vlieghe, Marc Vekemans, et al.. (2011). mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS. 26(4). F1–F12. 89 indexed citations
11.
Yansouni, Cédric P., et al.. (2011). The Use of Interferon-γ Release Assays for Tuberculosis Screening in International Travelers. Current Infectious Disease Reports. 13(3). 229–235. 2 indexed citations
12.
Zolfo, María, Jonathan Schapiro, Olivier Koole, et al.. (2010). Genotypic Impact of Prolonged Detectable HIV Type 1 RNA Viral Load after HAART Failure in a CRF01_AE-Infected Cohort. AIDS Research and Human Retroviruses. 27(7). 727–735. 14 indexed citations
13.
Bottieau, Emmanuel, Éric Florence, Jan Clerinx, et al.. (2008). Fever After a Stay in the Tropics: Clinical Spectrum and Outcome in HIV-Infected Travelers and Migrants. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(5). 547–552. 9 indexed citations
14.
Soentjens, Patrick, et al.. (2006). PORTAL VEIN THROMBOSIS IN A PATIENT WITH HIV TREATED WITH A PROTEASE INHIBITOR-CONTAINING REGIMEN. Acta Clinica Belgica. 61(1). 24–29. 8 indexed citations
15.
Georgala, Aspasia, Marc Vekemans, M. Husson, et al.. (2006). Zygomycosis in the immunocompromised patient: a case report.. PubMed. 77 Suppl 2. 5–9. 2 indexed citations
16.
Fanourgiakis, Panagiotis, Marc Vekemans, Aspasia Georgala, et al.. (2003). Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Supportive Care in Cancer. 11(5). 332–335. 16 indexed citations
17.
Fanourgiakis, Panagiotis, Aspasia Georgala, Marc Vekemans, et al.. (2003). Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute. Clinical Microbiology and Infection. 9(10). 1068–1072. 24 indexed citations
18.
Paesmans, Marianne, M. Barette, Aspasia Georgala, et al.. (2002). Oral empiric treatment and early hospital discharge for febrile neutropenic cancer patients predicted at low-risk by the MASCC score: experience at the Institut Jules Bordet. Supportive Care in Cancer. 10. 68. 1 indexed citations
19.
Vekemans, Marc, et al.. (1999). Potential source of human exposure to Mycobacterium bovis in Burkina Faso, in the context of the HIV epidemic. Clinical Microbiology and Infection. 5(10). 617–621. 15 indexed citations
20.
Hubrechts, Jelena, et al.. (1980). Isolation Of Chlamydia Trachomatis in Lymphogranuloma Venereum. Acta Clinica Belgica. 35(2). 76–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Shasha Breakdown of academic impact, for papers by Barbara Falkensammer Breakdown of academic impact, for papers by Anokhi J. Kapasi Breakdown of academic impact, for papers by Elizabeth Freda O. Telan Breakdown of academic impact, for papers by Hannah L. Itell Breakdown of academic impact, for papers by Ming Chang Breakdown of academic impact, for papers by Marissa B. Wilck Breakdown of academic impact, for papers by Mark K. Sachs Breakdown of academic impact, for papers by Margaret Duffy Breakdown of academic impact, for papers by Matthew M. Hernandez
Rankless by CCL
2026